Tumor Necrosis Factor-Alpha Inhibitor Use and Malignancy Risk: A Systematic Review and Patient Level Meta-Analysis.

ABSTRACT: Over the last two decades, tumor necrosis factor-alpha inhibitors (TNF-Is) have become standard therapies for chronic inflammatory disorders, with an ongoing expansion of indications and off-label applications [...].

SUBMITTER: Driscoll CB 

PROVIDER: S-EPMC11815771 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature